Article
Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
Carcinogenesis - 1 May 2006
Morimura Keiichirou, Cheung Connie, Ward Jerrold M, Reddy Janardan K, Gonzalez Frank J
Abstract excerpt
Peroxisome proliferators, such as lipid-lowering fibrate drugs, are agonists for the peroxisome proliferator-activated receptor alpha (PPARalpha). Sustained activation of PPARalpha leads to the development of liver tumors in rodents. Paradoxically, humans appear to be resistant to the induction of peroxisome proliferation and development of liver tumors by peroxisome proliferators. To examine the species...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
